万东医疗
(600055)
| 流通市值：121.63亿 | | | 总市值：121.63亿 |
| 流通股本：7.03亿 | | | 总股本：7.03亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,524,354,161.43 | 1,093,084,824.41 | 700,087,495.27 | 308,495,149.5 |
| 营业收入 | 1,524,354,161.43 | 1,093,084,824.41 | 700,087,495.27 | 308,495,149.5 |
| 二、营业总成本 | 1,361,474,392.59 | 973,078,073.01 | 611,620,342.22 | 277,816,152.47 |
| 营业成本 | 967,141,752.31 | 674,078,721.36 | 423,297,853.96 | 192,944,140.48 |
| 税金及附加 | 14,848,692.83 | 8,428,518.57 | 6,208,781.27 | 761,833.68 |
| 销售费用 | 219,402,271.74 | 163,365,259.28 | 99,975,282.03 | 49,631,679.54 |
| 管理费用 | 69,597,988.82 | 57,193,782.68 | 38,116,741.15 | 17,948,371.74 |
| 研发费用 | 165,233,686.54 | 115,518,473.81 | 78,990,672.31 | 35,189,394.52 |
| 财务费用 | -74,749,999.65 | -45,506,682.69 | -34,968,988.5 | -18,659,267.49 |
| 其中:利息费用 | 1,646,918.75 | 408,043.94 | 282,239.38 | - |
| 其中:利息收入 | 72,234,687.01 | 48,867,584.87 | 34,305,464.59 | 18,723,491.74 |
| 加:公允价值变动收益 | -2,998,534.83 | 1,186,506.84 | 781,476.7 | - |
| 加:投资收益 | 6,518,343.78 | 2,917,381.98 | 1,482,475.62 | 131,427.5 |
| 资产处置收益 | 120,751.58 | 26,630.39 | 24,509.44 | - |
| 资产减值损失(新) | -4,037,692.52 | -4,869 | -4,869 | - |
| 信用减值损失(新) | -25,427,314.05 | 2,377,444.55 | 2,377,444.55 | - |
| 其他收益 | 26,285,260.72 | 12,687,786.46 | 8,754,383.81 | 6,749,842.29 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 163,340,583.52 | 139,197,632.62 | 101,882,574.17 | 37,560,266.82 |
| 加:营业外收入 | 6,343,723.96 | 1,053,793.53 | 1,461,581.14 | - |
| 减:营业外支出 | 2,824,674.76 | 1,111,020.28 | 941,889.01 | 21,406.36 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 166,859,632.72 | 139,140,405.87 | 102,402,266.3 | 37,538,860.46 |
| 减:所得税费用 | 8,217,347.42 | 22,514,122.2 | 16,904,224.56 | 3,365,860.58 |
| 六、净利润 | 158,642,285.3 | 116,626,283.67 | 85,498,041.74 | 34,172,999.88 |
| 持续经营净利润 | 158,642,285.3 | 116,626,283.67 | 85,498,041.74 | 34,172,999.88 |
| 归属于母公司股东的净利润 | 157,350,997.13 | 115,733,364.5 | 84,741,768.09 | 33,257,419.94 |
| 少数股东损益 | 1,291,288.17 | 892,919.17 | 756,273.65 | 915,579.94 |
| (一)基本每股收益 | 0.22 | 0.17 | 0.12 | 0.05 |
| (二)稀释每股收益 | 0.22 | 0.17 | 0.12 | 0.05 |
| 八、其他综合收益 | -1,943,100 | - | - | - |
| 归属于母公司股东的其他综合收益 | -1,943,100 | - | - | - |
| 九、综合收益总额 | 156,699,185.3 | 116,626,283.67 | 85,498,041.74 | 34,172,999.88 |
| 归属于母公司股东的综合收益总额 | 155,407,897.13 | 115,733,364.5 | 84,741,768.09 | 33,257,419.94 |
| 归属于少数股东的综合收益总额 | 1,291,288.17 | 892,919.17 | 756,273.65 | 915,579.94 |
| 公告日期 | 2025-03-22 | 2024-10-26 | 2024-08-17 | 2024-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |